Misunderstood Lyme Disease and Lyme Disease Treatment Hurting Patients

Lyme Disease Misunderstood Leading to Unsatisfactory Lyme Disease Treatment Protocols

Lyme disease, also recognized as “the great imitator” is essentially one of the most misunderstood and widely growing illnesses in our country. Because its symptomology resembles that of so many other diseases and because our conventional medical community basically continues to be ill-informed, stricken patients fail to receive the Lyme disease treatment necessary to restore their health. Because Lyme disease is so generally misinterpreted, standard treatment typically lasts only four to six weeks, with extensive treatment widely believed to be unwarranted. As a result, many insurance companies refuse to cover appropriate treatment and residual Borrelia reemerges, thus, patients often relapse with Lyme or more importantly, Lyme Disease Complex. To further complicate matters, most

patients diagnosed with Lyme disease are ignorant of the full “complex” of co-infections and neurotoxins that reside in their system - eliminating the possibility of prescription medication as a viable, lone Lyme disease treatment.

Before We Can Talk About Lyme Disease Treatment, We Must Understand What Lyme Disease Complex Is

In the world of conventional medicine protocols, there is often lively debate regarding whether chronic Lyme disease is truly a bona fide disease, Others recognize that patients do indeed suffer with Lyme disease symptoms associated with Borrelia, contracted through tick bites. Unfortunately, most care providers do not have knowledgeable LLMDs (Lyme Literate Doctors) on staff who recognize the complexity, severity, and difficulty that encompasses Lyme disease treatment. To elicit a better understanding, the following are among the most common infections that can play a role in Lyme disease. They are all potential contributors to what Envita Medical Centers labels Lyme disease complex – a confluence of infections that may simultaneously include bacterial, viral, parasitic, and fungal co-infections that all necessitate specific Lyme disease treatment and protocol customization to aid patients in the long term.

1. Borrelia (B. burgdorferi) – The most recognized infection in Lyme disease which is often deemed to be the tick-borne variety. While it is a major contributor, borrelia alone makes up but one of the numerous infections that stimulate Lyme disease and ostensibly make treatment so difficult.

2. Bartonella – Bartonellahenselae is the causative agent of the notorious cat-scratch fever, endocarditis, and countless other serious diseases known to humans. These bacteria comprise one of Lyme disease complex’s most irksome co-infections. The bacteria are transferred by fleas, body lice, and ticks – with ticks being the greatest source of human bartonellosis infection, often accompanied by Lyme disease. Sand flies transport the bacteria in Peru’s Andes Mountains, Colombia, and Ecuador while human body lice carriers are distributed throughout the world. The European sheep tick is a known carrier and five different species of Bartonella have been detected in nearly 20 percent of I. Pacificus ticks collected in California.

3. Epstein-Barr (HHV-4) – This is a common human herpes virus that will infect virtually every individual on our planet at some juncture in their lifetime. It is indeed possible for EBV to lie dormant in the body throughout one’s life span. Typically, the disease is transmitted via saliva and requires 30-45 days to present with symptoms – if it eventually does at all. During this cycle of time, the host is most likely to spread EBV to others. However, when these infections continue to manifest as seen in chronic fatigue patients it becomes essential to evaluate/test for chronic Lyme disease complex and its co-infections and immunity. Lyme disease treatment becomes a requirement as multiple infections can often awaken dormant insidious infections such as Epstein-Barr.

4. Cytomegalovirus (CMV) - Approximately 80 percent of adults in these United States are infected with cytomegalovirus (CMV). It is considered a member of the herpes family and shares the common trait of remaining alive, yet dormant, in the human body for the ongoing life span of its human host. Rarely does CMV become active unless the immune system is compromised– as it can easily be (and most often is) with Lyme disease infections deteriorating the immune system.

5. Babesiosis- Intraerythrocytic parasite Babesia microiti causes Babesiosis, an infection that resides inside red blood cells. It is transmitted by the identical tick that transmits B. burgdorferi, the causative agent of Lyme disease. Forty one percent of patients stricken with Babesia develop serious complications which may include acute respiratory failure, disseminated intravascular coagulation, congestive heart or renal failure. Complex babesiosis is regularly associated with the presence of severe anemia and high parasitaemia levels. Chronic babesia has been known to trigger cardiovascular, kidney, and liver problems in patients. Babesiosis is clearly a dangerous component of Lyme disease and must be tested for, and if necessary, marginalized with a comprehensive Lyme disease treatment.

6. Human Herpes Virus 6 – Lyme disease complex may also include human herpes virus 6. (HHV-6) has since become one of the most widespread members of human herpes viruses and presents in two related variants: HHV-6A and HHV-6B. HHV-6 is known to attack specific cells including but not limited to CD 4 lymphocytes, NKTs, oligodedrocytes, CD8 cells, and microglial cells. For your information, this virus is immune suppressive and also activates other viruses during the process. While HHV-6 can remain latent for long periods of time, it can reactivate and produce infection quickly. A comprehensive Lyme disease treatment must be introduced to combat HHV-6 and other Lyme disease complex infections.

7. Ehrlichiosis - Ehrlichiosis is a serious Lyme disease co-infection disease caused by rickettsial-type (specific bacteria) organisms and presents in two specific forms; Human Monocytic Ehrlichiosis (HME) and Human Granulocytic Ehrlichiosis (HGE). In the majority of cases, Ehrlichiosis is self-limiting and not fatal with death rates in large, unselected series ranging from 1 to 8 percent [3,6-8]. This contrasts sharply with the high death rate in patients who are immunocompromised. Definitively, however, Lyme disease patients are relegated to the dangerous “immunocompromised” category. That is why it is incumbent upon patients to receive an aggressive and comprehensive Lyme disease treatment plan.

8. Chlamydia pneumonia - Chlamydophila pneumoniae (formerly known as Chlamydia pneumoniae or CP) are bacteria that infect humans and can trigger pneumonia. They are a type of Chlamydia . Chlamydophila pneumoniae has a complex life cycle and must infect another cell in order to reproduce itself. The disease generally begins as a respiratory infection, appearing more or less unnoticed in the body and spreads to infect other tissues such as nerves, brain, muscles, blood vessels and even cells defending the body's own immune system, the macrophages. CP itself produces at least two toxic substances that initiate tissue destruction and inflammatory burden, as well as a chronic immune activation and invasion with a toxin load. CP survives in the cell much as a parasite taps energy in order to reproduce. Therapy, however, must be administered effectively until CP is destroyed in all three stages, thus voiding re-infection. It is a critical part of Lyme disease treatment in cases where CP is present.

9. Candida - The most common organism implicated in fungal infections is the ubiquitous Candida, which is evidenced in the human digestive tract, mouth, and genital region (Eggiman P et al 2003). Under normal circumstances, levels of Candida are controlled by beneficial bacteria. However, if the bacteria-fungus balance is skewed, by the use of antibiotics for example, or if the immune system is compromised, an overgrowth of Candida can occur, resulting in infection. As the immune system is always weakened by the presence of chronic Lyme disease - the presence of Candida must be aggressively addressed in a comprehensive Lyme disease treatment.

As comprehensive as the above maladies seem, it is equally important to point out that only 13% of infections that exist around the world have actually been identified. Among these are zoonotic infections (those emanating from animals) - making Lyme disease treatment among the most complex to approach.

The Reality of Lyme Disease and Lyme Disease Treatments That Can Actually Work

If Lyme disease is diagnosed early, it can be treated reasonably well with a regimen of antibiotics. However, in the great majority of cases, Lyme disease is not identified by either the patients or their physicians at its onset - if ever. For patients who have had Lyme disease for over a year, significantly more extensive treatment is necessary.

The standard prescription of antibiotics is generally substantially insufficient in treating Lyme disease complex or as a singular Lyme disease treatment. Antibiotics do not help the body rid itself of the mycotoxins or BLP (bacteria lipoprotein neurotoxins) caused by Borrelia, nor are they effective in treating the various viral, fungal, and parasitic co-infections attendant to Lyme disease. These co-infections are exhibited in some combination in virtually every Lyme disease patient and must be addressed within any worthwhile Lyme disease treatment.

In fact, is not rare to see four or more combinations of infections in chronic Lyme disease patients. Often months, or even several years of treatment are deemed necessary to erase the stubborn Borrelia from the body – not to mention the multitudes of other attackers liberated

by the presence of Lyme disease complex in the body. Chronic Lyme disease treatment requires an organized and customized program that includes reestablishment of immune function and status for patients. Simply administering medication will not suffice and can even complicate the situation. For example, physicians who attempt to treat patients using anti-malaria drugs such as plaquenil, commonly fall short as they neglect to address the immune system.

Chronic Lyme Disease Awareness and Effective Lyme Disease Treatment

Treatment of Lyme disease must be targeted at more than just the infections. Diminishing inflammation, supporting the immune system, detoxification of BLP’s, and addressing hormone deficiencies are crucial to a comprehensive chronic Lyme disease treatment plan. If patients are ingesting other medications or pain killers, a delicate approach is needed to transition them to a superior quality of life. In fact, when patient indicate that they have Lyme disease, or Lyme disease doctors examine patients - it is a commonly recognized that they are dealing with a combination of infections, as well as an immune compromised state. While the infections present may vary from case to case, the basic existing problem is Lyme disease complex, or "a combination of infections”.

Envita’s Experience is the Difference for Lyme Disease Patients and Life-changing Lyme Disease Treatment

Envita has worked in the areas of Lyme disease research and Lyme disease treatment for nearly a decade. Our experiences have led to faster, more effective advances in Lyme disease treatment. At Envita, we address and examine all elements of Lyme disease, understanding that handling Lyme’s co-infections is just as crucial as direct treatment of the primary disease. Recognizing the concept of co-infections and body’s homeostasis imbalances is exactly why we label it Lyme disease complex and why Envita leads the World in effective Lyme disease treatment.

To further exacerbate matters, many Lyme disease infections dwell within the red and white bloods cells making them very stealth and as a result, extremely unresponsive to treatment. They can defeat the body's immune defenses and reproduce within the healthy cells. Envita takes advantage of special shuttling agents to effectively address and marginalize these infections.

Lyme Disease Treatment and Complications of Lyme Disease

There has been much dialogue about Bioflim communities that protect the infections from the penetration of medications. In many cases these Biofilm communities must be stripped and minimized through proper treatment and lifestyle changes.

Another scenario to consider, as it pertains to Lyme disease treatment, is self-synergistic replication. In this situation, many infections can communicate with and stimulate the replication of other viruses already present in the body. All the while, the patient must contend with numerous symptoms that may present as digestion problems, cognitive difficulties, chronic pain, sleep deprivation, and hormonal imbalances - just to mention a few.

Does Chronic Lyme Disease Exist and is Lyme Disease Treatment Necessary

Lyme disease does undeniably exist. And even though many researchers will imply that the patient really does not have Lyme disease in the classical laboratory form – patients often still suffer from a combination of the infections aforementioned . Presumably, they must be treated simultaneously so as to provide effective and sustained relief for patients.

It is also vital to realize that many laboratory tests provide false negatives .The tests decree a negative finding when the patient actually has an infection(s) present. Some of the most common reasons are immune systems that are too compromised to mount a proper antigen test. However, if an immune system challenge is conducted, one may notice a positive test result for these patients. Additionally, many of these infections do live intra-cellularly and as a return with false negative results.

At Envita, we have developed a bold combination of tests to identify specific immunological factors and a comprehensive clinical overview to help patients seek and treat all the components of the Lyme Disease complex.

Envita’s Approach to Tackling Lyme Disease and Identifying the Ideal Lyme Disease Treatment for Each Patient

Because Lyme disease is so complex, extensive and comprehensive Lyme disease treatment is required.. At Envita, Lyme disease treatments are not limited to antibiotics, rather administered in conjunction with aggressive natural therapies from locations all over the world.

As part of our Disease Solutions Program®, we take an integrative approach to Lyme disease treatment, utilizing anti-viral, anti-parasitic, and anti-fungal approaches - depending on the co-infections and symptoms present in each patient. By addressing all Lyme disease complex factors, we achieve superior results with our incomparable Lyme disease treatments.

We implement innovative treatments to help patients achieve an intensive-grasp of their disease, thereby providing them with the ability to conquer. Our comprehensive approach to treatment helps speed healing time, enhance quality of life, and minimize the recurrence of Lyme disease. To learn more about our Lyme disease treatment protocols or glean more knowledge about Lyme disease itself, contact us at Envita Medical Centers today.